|本期目录/Table of Contents|

[1]刘莲莲 综述,李广平 审校.由Block-HF临床试验看心室同步化治疗的进展[J].天津医科大学学报,2016,22(06):547-550.
点击复制

由Block-HF临床试验看心室同步化治疗的进展(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
22卷
期数:
2016年06期
页码:
547-550
栏目:
综述
出版日期:
2016-11-20

文章信息/Info

Title:
-
文章编号:
1006-8147(2016)06-0547-4
作者:
刘莲莲 综述; 李广平 审校
（天津市心血管病离子与分子机能重点实验室，天津医科大学第二医院心脏科，天津心脏病学研究所，天津 300211）
Author(s):
-
关键词:
心脏再同步化治疗; 右室起搏;  QRS波群
Keywords:
-
分类号:
R541.6
DOI:
-
文献标志码:
A
摘要:
-
Abstract:
-

参考文献/References:

[1]Ruwald A C, Kutyifa V, Ruwald M H, et al. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling[J]. Eur Heart J, 2015, 36(7): 440

[2]Abraham W T, Fisher W G, Smith A L. Cardiac resynchronization in chronic heart failure[J]. ACC Curr J Rev, 2002, 11 (6): 75

[3]王方正，张澍，黄德嘉，等．心脏再同步治疗慢性心力衰竭的建议[J]．中华心律失常学杂志，2006，10（2）：90

[4]Rivero-Ayerza M, Theuns D A, Garcia-Garcia H M, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: Ameta-analysis of randomized controlled trials[J]. Eur Heart J, 2006,27(22):2682

[5]Auricchio A, Metra M, Gasparini M, et al. Multicenter Longitudinal Observation Study (MILOS) Group. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy[J]. Am J Cardiol, 2007;99(2): 232

[6]Huang J, Yang J, Zhang J. Chinese guidelines for the diagnosis and treatment of heart failure2014[J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2014, 42(2): 98

[7]Sweeney M O, Hellkamp A S, Ellenbogen K A, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction[J]. Circulation, 2003, 107(23): 2932

[8]Fanari Z, Hammami S, Hammami M B, et al. The effects of right ventricular apical pacing frequency on left ventricle function and pulmonary artery pressure[J]. Del Med J, 2015, 87(8): 244

[9]Bank A J, Gage R M, Burns K V. Right ventricular pacing, mechanical dyssynchrony, and heart failure[J]. J Cardiovasc Transl Res, 2012, 5(2): 219

[10]Bristow M R, Saxon L A. Cardiac-resynchronization therapywith or without an implantable defibrillator in advanced chronic heart failure[J]. N Engl J Med, 2004, 350(21): 2140

[11]Curtis A B, Adamson P B, Chung E, et al. Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): Clinical study design and rationale[J]. J Cardiovasc Electrophysiol, 2007, 18(9): 965

[12]Curtis A B, Worley S J, Adamson P B, et al. Biventricular pacing for atrioventricular block and systolic dysfunction[J]. N Engl J Med, 2013, 368(17): 1585

[13]Sutton M S, Plappert T, Adamson P B, et al. Left ventricular reverse remodeling with biventricular versus right ventricular pacing in patients with atrioventricular block and heart failure in the BLOCK HF trial[J]. Circ Heart Fail, 2015, 8(3): 510

[14]Linde C, Abraham W T, Gold M R, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms[J]. J Am Coll Cardiol, 2008, 52(23): 1834

[15]Moss A J, Hall W J, Cannom D S, et al. Cardiac-Resynchronization therapy for the prevention of Heart-Failure events[J]. N Engl J Med, 2009, 361(14): 1329

[16]Birnie D H, Ha A, Higginson L, et al. Impact of QRS morphology and durationon outcomes after cardiac resynchronization therapy: results fromthe resynchronization-Defibrillation for Ambulatory Heart FailureTrial (RAFT). Circ Heart Fail, 2013,6(6):1190

[17] JCS Joint Working Group. Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias(JCS 2011)[J]. Circ J，1994，77（1）：51

[18]Mcalister F, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction:A systemic review[J]. JAMA, 2007(297): 2502

[19]Shamim W, Francis D P, Yousfuddin M, et al. Intraventricular conduction delay:aprognostic maker in chronic heart failure[J]. Int J Cardiol, 1999, 70(2): 171

[20]Imamura T, Kinugawa K, Nitta D, et al. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure[J]. Circulation Journal, 2015, 79(11): 2414

[21]Van Bommel R J, Tanaka H, Delgado V A, et al. Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex[J]. Eur Heart J, 2010, 31(24): 3054

[22]Migliore F, Baritussio A, Stabile G, et al. Prevalence of true left bundle branch block in current practice of cardiac resynchronization therapy implantation[J]. J Cardiovasc Med (Hagerstown), 2016, 17(7): 462

[23]Russo A M, Stainback R F, Bailey S R, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy:a reportof the American CollegeofCardiology Foundation appropriate use criteria task force,Heart Rhythm Society,American Heart Association,American Society of Echocardiography,Heart Failure Society of America,Society for Cardiovascular Angiography and Interventions,Society of Cardiovascular Computed Tomography,and Society for Cardiovascular Magnetic Resonance[J]. J Am Coll Cardiol, 2012, 61(12): 1318

[24]Israel C, Anker S D, Hasenfuss G, et al. Commentary on the 2010 ESC guidelines on device therapy in heart failure[J]. Herzschrittmacherther Elektrophysiol, 2012, 23(1): 33

相似文献/References:

备注/Memo

备注/Memo:
作者简介 刘莲莲（1989-），女，硕士在读，研究方向：心血管内科； E-mail: 528653481@qq.com。

更新日期/Last Update: 2016-11-25